Skip to content

Texas Capital Bancshares Inc/TX: META position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Texas Capital Bancshares Inc/TX on META, newest first. How the timeline and the estimate are built.

Texas Capital Bancshares Inc/TX held 993 META shares at 2025-09-30 per its 13F-HR filed 2025-11-13.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 993 shares
    Change vs previous 13F -472 shares

    0.29% of the 13F portfolio, value $729,241.

    13F-HR 0001077428-25-000152 filed by Texas Capital Bancshares Inc/TX
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-06-30
    13F 1,465 shares
    Change vs previous 13F +7 shares

    0.39% of the 13F portfolio, value $1,081,301.

    13F-HR 0001077428-25-000139 filed by Texas Capital Bancshares Inc/TX
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 1,458 shares
    Change vs previous 13F +29 shares

    0.36% of the 13F portfolio, value $840,332.

    13F-HR 0001077428-25-000119 filed by Texas Capital Bancshares Inc/TX
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 1,429 shares
    Change vs previous 13F +437 shares

    0.34% of the 13F portfolio, value $836,692.

    13F-HR 0001077428-25-000043 filed by Texas Capital Bancshares Inc/TX
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 992 shares
    Change vs previous 13F not available

    0.23% of the 13F portfolio, value $567,860.

    13F-HR 0001077428-24-000190 filed by Texas Capital Bancshares Inc/TX
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).